Literature DB >> 1993481

Reduction of biological activity of murine recombinant interleukin-1 beta by selective deamidation at asparagine-149.

G O Daumy1, C L Wilder, J M Merenda, A S McColl, K F Geoghegan, I G Otterness.   

Abstract

A biologically active preparation of murine recombinant interleukin-1 beta (mIL-1 beta) from Escherichia coli cell lysates contained tow forms of mIL-1 beta with pI 8.7 and pI 8.1, respectively. Treatment with 0.1 M Tris, pH 8.5, at 37 degrees C for 35 h converted the pI 8.7 form to the pI 8.1 form by the selective deamidation of an asparagine residue (Asn149) in the mIL-1 beta molecule. Deamidated mIL-1 beta had 3- to 5-fold lower co-mitogenic activity and receptor affinity than the unmodified form.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1993481     DOI: 10.1016/0014-5793(91)80093-i

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  Prediction of protein deamidation rates from primary and three-dimensional structure.

Authors:  N E Robinson; A B Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

2.  Protein modification by deamidation indicates variations in joint extracellular matrix turnover.

Authors:  Jonathan B Catterall; Ming F Hsueh; Thomas V Stabler; Christopher R McCudden; Michael Bolognesi; Robert Zura; Joanne M Jordan; Jordan B Renner; Sheng Feng; Virginia B Kraus
Journal:  J Biol Chem       Date:  2011-12-16       Impact factor: 5.157

3.  The role of tumour necrosis factor-alpha and IL-1 in polymorphonuclear leucocyte and T lymphocyte recruitment to joint inflammation in adjuvant arthritis.

Authors:  A C Issekutz; A Meager; I Otterness; T B Issekutz
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

4.  Changes in Mobility of the Golden Hamster with Induction of an IL-1-Induced Arthritis.

Authors:  I G Otterness; M L Bliven; A J Milici
Journal:  Mediators Inflamm       Date:  1994       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.